Advertisement

Oncology

Though patient enrollment in clinical trials for cancer therapies has slowed as a result of the COVID-19 pandemic, and some institutions have halted trials altogether, other trials are continuing with modified protocols, according to STAT News.

Advertisement

The cost of cancer-related care is projected to increase 34 percent in the next decade, according to a study published in Cancer Epidemiology, Biomarkers & Prevention. 

As countries end lockdowns and coronavirus-related restrictions gradually lift, hospitals are expecting to see an influx of cancer patients who may have delayed their care as the pandemic spread across the world, Bloomberg reports.

Advertisement